Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Jun'25
Net Sales
218.15
245.25
203.17
Other Operating Income
0.00
0.00
0.00
Total Operating income
218.15
245.25
203.17
Raw Material Cost
75.56
91.12
77.33
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
46.42
42.33
35.14
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
50.98
49.71
32.73
Total Expenditure (Excl Depreciation)
172.96
183.16
145.20
Operating Profit (PBDIT) excl Other Income
45.19
62.09
57.97
Other Income
0.34
0.16
2.64
Operating Profit (PBDIT)
45.53
62.25
60.61
Interest
6.18
7.26
5.28
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
39.35
54.99
55.33
Depreciation
21.82
19.75
10.51
Profit Before Tax
17.53
35.25
44.82
Tax
3.47
7.71
14.90
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
14.06
27.53
29.92
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
14.06
27.53
29.92
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.01
0.02
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
14.06
27.51
29.92
Equity Capital
12.85
12.85
12.85
Face Value
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
2.19
4.28
4.66
Diluted Earnings per share
2.24
4.76
5.34
Operating Profit Margin (Excl OI)
20.72%
25.32%
28.53%
Gross Profit Margin
18.04%
22.42%
27.23%
PAT Margin
6.45%
11.23%
14.73%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is -1.05% vs 4.32% in Mar 2026
Standalone Net Profit
QoQ Growth in quarter ended Jun 2026 is 399.62% vs -135.25% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 21.05% vs -21.50% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is -12.87% vs 26.22% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
Compare Quarterly Results Of Symbiotec Pharma With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
218.15
535.90
-317.75
-59.29%
Other Operating Income
0.00
0.00
0.00
Total Operating income
218.15
535.90
-317.75
-59.29%
Raw Material Cost
75.56
75.70
-0.14
-0.18%
Purchase of Finished goods
0.00
84.10
-84.10
-100.00%
(Increase) / Decrease In Stocks
0.00
80.70
-80.70
-100.00%
Employee Cost
46.42
53.80
-7.38
-13.72%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
50.98
69.70
-18.72
-26.86%
Total Expenditure (Excl Depreciation)
172.96
364.00
-191.04
-52.48%
Operating Profit (PBDIT) excl Other Income
45.19
171.90
-126.71
-73.71%
Other Income
0.34
3.30
-2.96
-89.70%
Operating Profit (PBDIT)
45.53
175.20
-129.67
-74.01%
Interest
6.18
0.30
5.88
1,960.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
39.35
174.90
-135.55
-77.50%
Depreciation
21.82
9.60
12.22
127.29%
Profit Before Tax
17.53
165.30
-147.77
-89.40%
Tax
3.47
45.80
-42.33
-92.42%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
14.06
119.50
-105.44
-88.23%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
14.06
119.50
-105.44
-88.23%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.01
0.00
0.01
Other related items
0.00
0.00
0.00
Consolidated Net Profit
14.06
119.50
-105.44
-88.23%
Equity Capital
12.85
23.00
-10.15
-44.13%
Face Value
2.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
2.19
51.96
-49.77
-95.79%
Diluted Earnings per share
2.24
51.89
-49.65
-95.68%
Operating Profit Margin (Excl OI)
20.72%
32.08%
0.00
-11.36%
Gross Profit Margin
18.04%
32.64%
0.00
-14.60%
PAT Margin
6.45%
22.30%
0.00
-15.85%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 210.84 Cr
in Jun 2026Figures in Cr
QoQ Growth in quarter ended Jun 2026 is -1.05% vs 4.32% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 3.22%
Quarterly - Standalone Net Profit
Standalone Net Profit 47.01 Cr
in Jun 2026Figures in Cr
QoQ Growth in quarter ended Jun 2026 is 399.62% vs -135.25% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 5.62%
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 59.24 Cr
in Jun 2026Figures in Cr
QoQ Growth in quarter ended Jun 2026 is 21.05% vs -21.50% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -4.97%
Quarterly - Interest
Interest 5.62 Cr
in Jun 2026Figures in Cr
QoQ Growth in quarter ended Jun 2026 is -12.87% vs 26.22% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 9.98%
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.10%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
